Lipoprotein-Associated and Secreted Phospholipases A 2 in Cardiovascular Disease
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipoprotein-Associated and Secreted Phospholipases A
2
in Cardiovascular Disease
Authors
Keywords
-
Journal
CIRCULATION
Volume 122, Issue 21, Pages 2183-2200
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2010-11-23
DOI
10.1161/circulationaha.110.936393
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidation-Specific Biomarkers, Lipoprotein(a), and Risk of Fatal and Nonfatal Coronary Events
- (2010) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Capacity of Group V sPLA 2 to Increase Atherogenicity of ApoE −/− and LDLR −/− Mouse LDL In Vitro Predicts its Atherogenic Role In Vivo
- (2009) Boris Boyanovsky et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Increased PAFAH and Oxidized Lipids Are Associated With Inflammation and Atherosclerosis in Hypercholesterolemic Pigs
- (2009) Dieuwke De Keyzer et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipoprotein-associated phospholipase A2, inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
- (2009) Muriel J. Caslake et al. ATHEROSCLEROSIS
- Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma
- (2009) Constantinos C. Tellis et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Future Role for Selective Phospholipase A2 Inhibitors in the Prevention of Atherosclerotic Cardiovascular Disease
- (2009) Robert S. Rosenson CARDIOVASCULAR DRUGS AND THERAPY
- Lipoprotein modification by secretory phospholipase A2 enzymes contributes to the initiation and progression of atherosclerosis
- (2009) Katariina Öörni et al. CURRENT OPINION IN LIPIDOLOGY
- Expression of lipoprotein-associated phospholipase A2 in carotid artery plaques predicts long-term cardiac outcome
- (2009) J. Herrmann et al. EUROPEAN HEART JOURNAL
- Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease
- (2009) W. Koenig et al. EUROPEAN HEART JOURNAL
- Darapladib
- (2009) Quang T Bui et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Atherosclerotic plaque development
- (2009) Quang T. Bui et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Activation of Cytosolic Phospholipase A2-α as a Novel Mechanism Regulating Endothelial Cell Cycle Progression and Angiogenesis
- (2009) Shane P. Herbert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Varespladib (A-002), a Secretory Phospholipase A2 Inhibitor, Reduces Atherosclerosis and Aneurysm Formation in ApoE−/− Mice
- (2009) Heather Fraser et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Molecular and functional characterization of polymorphisms in the secreted phospholipase A2 group X gene: relevance to coronary artery disease
- (2009) Sarah Gora et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial
- (2009) Robert S Rosenson et al. LANCET
- G2A and LPC: Regulatory functions in immunity
- (2009) Janusz H. Kabarowski PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Lipoprotein-Associated Phospholipase A 2 and C-Reactive Protein for Risk-Stratification of Patients With TIA
- (2009) Brett L. Cucchiara et al. STROKE
- Biochemistry and Physiology of Mammalian Secreted Phospholipases A2
- (2008) Gérard Lambeau et al. Annual Review of Biochemistry
- Lipid Mediators in Health and Disease: Enzymes and Receptors as Therapeutic Targets for the Regulation of Immunity and Inflammation
- (2008) Takao Shimizu Annual Review of Pharmacology and Toxicology
- Cardiovascular Events With Increased Lipoprotein-Associated Phospholipase A 2 and Low High-Density Lipoprotein-Cholesterol
- (2008) Sander J. Robins et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Prostanoid and isoprostanoid pathways in atherogenesis
- (2008) Domenico Praticò ATHEROSCLEROSIS
- Lp-PLA2 activity and mass are associated with increased incidence of ischemic stroke
- (2008) Margaretha Persson et al. ATHEROSCLEROSIS
- Group IVA Phospholipase A2-Associated Production of MMP-9 in Macrophages and Formation of Atherosclerotic Lesions
- (2008) Hiromi Ii et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)
- (2008) Diana M. Stafforini CARDIOVASCULAR DRUGS AND THERAPY
- Lipoprotein-Associated Phospholipase A2 Activity and Risk of Recurrent Stroke
- (2008) Mitchell S.V. Elkind et al. CEREBROVASCULAR DISEASES
- Effects of the Direct Lipoprotein-Associated Phospholipase A 2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque
- (2008) Patrick W. Serruys et al. CIRCULATION
- Group VI Phospholipases A2: Homeostatic Phospholipases with Significant Potential as Targets for Novel Therapeutics
- (2008) W. Wilkins III et al. CURRENT DRUG TARGETS
- Oxidized phospholipids: emerging lipid mediators in pathophysiology
- (2008) Hans-Peter Deigner et al. CURRENT OPINION IN LIPIDOLOGY
- Impact of a combined treatment of angiotensin II type 1 receptor blockade and 3-hydroxy-3-methyl-glutaryl-CoA-reductase inhibition on secretory phospholipase A2-type IIA and low density lipoprotein oxidation in patients with coronary artery disease
- (2008) D. Divchev et al. EUROPEAN HEART JOURNAL
- Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case–control and family datasets
- (2008) Beth S. Sutton et al. HUMAN MOLECULAR GENETICS
- Lipoprotein-Associated Phospholipase A 2 , Hormone Use, and the Risk of Ischemic Stroke in Postmenopausal Women
- (2008) Sylvia Wassertheil-Smoller et al. HYPERTENSION
- Analyses of Group III Secreted Phospholipase A2Transgenic Mice Reveal Potential Participation of This Enzyme in Plasma Lipoprotein Modification, Macrophage Foam Cell Formation, and Atherosclerosis
- (2008) Hiroyasu Sato et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Crystal Structure of Human Plasma Platelet-activating Factor Acetylhydrolase
- (2008) Uttamkumar Samanta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Macrophage Secretory Phospholipase A2Group X Enhances Anti-inflammatory Responses, Promotes Lipid Accumulation, and Contributes to Aberrant Lung Pathology
- (2008) Daniëlle M. J. Curfs et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- iPLA2β: front and center in human monocyte chemotaxis to MCP-1
- (2008) Ravi S. Mishra et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The synergistic inhibition of atherogenesis in apoE−/−mice between pravastatin and the sPLA2inhibitor varespladib (A-002)
- (2008) Zory Shaposhnik et al. JOURNAL OF LIPID RESEARCH
- The emerging roles of PAF acetylhydrolase
- (2008) Thomas M. McIntyre et al. JOURNAL OF LIPID RESEARCH
- The role of oxidized phospholipids in atherosclerosis: Fig. 1.
- (2008) Judith A. Berliner et al. JOURNAL OF LIPID RESEARCH
- Highly Specific and Broadly Potent Inhibitors of Mammalian Secreted Phospholipases A2
- (2008) Rob C. Oslund et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart Disease Risk Equivalent
- (2008) Emile R. Mohler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lipoprotein-Associated Phospholipase A2 Is an Independent Predictor of Incident Coronary Heart Disease in an Apparently Healthy Older Population
- (2008) Lori B. Daniels et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic variants and haplotypes of lipoprotein associated phospholipase A2 and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study)
- (2008) M. M. HOFFMANN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Can endogenous lipid molecules serve as predictors and prognostic markers of coronary heart disease?
- (2008) Undurti N Das Lipids in Health and Disease
- Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development
- (2008) Robert L Wilensky et al. NATURE MEDICINE
- Lipid signalling in disease
- (2008) Matthias P. Wymann et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Platelet-Activating Factor, PAF Acetylhydrolase, and Severe Anaphylaxis
- (2008) Peter Vadas et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started